| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.6161 | 25 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.5904 | 30 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.7983 | 17 |
| GSM780719 | Untreated after 4 days (C1_2) | 36.197 | 1 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.5071 | 34 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.6184 | 35 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.0547 | 32 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.0337 | 41 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.4336 | 43 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.0659 | 27 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.4327 | 24 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.0355 | 18 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.201 | 14 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.1095 | 42 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 45.871 | 31 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.5822 | 25 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 40.1769 | 7 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.7197 | 12 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.4175 | 29 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.1392 | 52 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.2197 | 18 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.4525 | 29 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 42.2087 | 14 |